Trevi Therapeutics Inc (NASDAQ:TRVI) shares, rose in value on Thursday, March 27, with the stock price up by 0.85% to the previous day’s close as strong demand from buyers drove the stock to $6.53. Actively observing the price movement in the last trading, the stock
The trading price of Trevi Therapeutics Inc (NASDAQ:TRVI) closed lower on current market day and closing at $6.40, -1.08% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $6.22 and $6.52. In examining the
Trevi Therapeutics Inc (NASDAQ:TRVI) price on Thursday, March 20, fall -2.94% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.61. A look at the stock’s price movement, the close in the last trading session was $6.81, moving
Trevi Therapeutics Inc (NASDAQ:TRVI) price closed higher on current market day and jumping 7.31% above its previous close. A look at the daily price movement shows that the last close reads $6.29, with intraday deals fluctuated between $6.275 and $6.78. The company’s 5Y monthly beta
Trevi Therapeutics Inc (NASDAQ:TRVI) traded at $6.07 at close of the session on Monday, March 10 and made an upward move of 41.16% on its previous day’s price. Trevi Therapeutics Inc has a market cap of $542.45 million and is expected to release its quarterly
Trevi Therapeutics Inc (NASDAQ:TRVI) price closed lower on Friday, February 21, and dropping -4.17% below its previous close. A look at the daily price movement shows that the last close reads $4.80. Taking into account the 52-week price action we note that the stock hit
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
